Orange Book product · Generic (ANDA)
ELIGLUSTAT TARTRATE
ELIGLUSTAT TARTRATE
At a glance
Sep 08, 2021
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 08, 2021
4 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
ELIGLUSTAT TARTRATE
Strength
EQ 84MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 212463
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ELIGLUSTAT TARTRATE
- 2014CERDELGABrand (NDA)
NDA 205494 · GENZYME CORP
- 2024ELIGLUSTAT TARTRATEGeneric (ANDA)
ANDA 212369 · CIPLA
- 2024ELIGLUSTAT TARTRATEGeneric (ANDA)
ANDA 212425 · APOTEX
- 2023ELIGLUSTAT TARTRATEGeneric (ANDA)
ANDA 212420 · UPSHER SMITH LABS
- 2022ELIGLUSTAT TARTRATEGeneric (ANDA)
ANDA 212449 · DR REDDYS
- 2021ELIGLUSTAT TARTRATEGeneric (ANDA)
ANDA 212474 · TEVA PHARMS USA INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
